Related Experiment Video
Updated: Jun 25, 2026
08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
HLA-DQ7 beta(1) and beta(2) derived peptides as immunomodulators
Theodore Skarlas1, Eugenia Panou-Pomonis, Alicja Kluczyk
1Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
Summary
Small molecules mimicking HLA-DQ7 interfaces can modulate immune responses. Researchers designed peptide analogs to block autoimmune reactions, with some showing significant immunosuppressive activity in vitro.
Area of Science:
- Immunology
- Molecular Biology
- Drug Discovery
Background:
- Autoimmune diseases are linked to human leukocyte antigen (HLA) variations.
- Modulating protein-protein interactions in the immune system offers therapeutic potential for autoimmune disorders.
Purpose of the Study:
- To design and synthesize small molecular mimics of HLA-DQ7 interfaces.
- To investigate the immunomodulatory activities of these peptide analogs.
Main Methods:
- Modeled HLA-DQ7 beta-regions and identified key peptide fragments (132-141 and 58-67).
- Synthesized linear, cyclic, and dimeric peptide analogs.
- Assessed immunosuppressive activity in vitro using a secondary humoral immune response to sheep erythrocytes (SRBC) in mice.
Main Results:
- Peptide analogs exhibited immunosuppressive activities ranging from 11% to 53%.
- Investigated the role of peptide charge, hydrogen bonding, and secondary structure in immunomodulation.
- Dimeric analogs of the 58-67 fragment showed potential for modulating T-cell receptor (TCR)/HLA interactions, acting as immunostimulators at low concentrations.
Conclusions:
- Small molecule mimics of HLA-DQ7 can modulate immune responses.
- Peptide analogs, particularly dimeric forms of the 58-67 fragment, hold promise for developing novel immunotherapies targeting autoimmune diseases.
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...